[go: up one dir, main page]

HK1067372A - Crystal structure of baff, and use thereof in drug design - Google Patents

Crystal structure of baff, and use thereof in drug design Download PDF

Info

Publication number
HK1067372A
HK1067372A HK04110355.4A HK04110355A HK1067372A HK 1067372 A HK1067372 A HK 1067372A HK 04110355 A HK04110355 A HK 04110355A HK 1067372 A HK1067372 A HK 1067372A
Authority
HK
Hong Kong
Prior art keywords
baff
crystal structure
drug design
drug
design
Prior art date
Application number
HK04110355.4A
Other languages
Chinese (zh)
Inventor
Michael Karpusas
Original Assignee
Biogen Idec Ma Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Idec Ma Inc. filed Critical Biogen Idec Ma Inc.
Publication of HK1067372A publication Critical patent/HK1067372A/en

Links

HK04110355.4A 2001-09-06 2002-09-06 Crystal structure of baff, and use thereof in drug design HK1067372A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60/317,524 2001-09-06

Publications (1)

Publication Number Publication Date
HK1067372A true HK1067372A (en) 2005-04-08

Family

ID=

Similar Documents

Publication Publication Date Title
AU2002353790A1 (en) Syringe and reconstitution syringe
AU2002341959A1 (en) Drug delivery devices and methods
AU2003217531A1 (en) Ocular drug delivery systems and use thereof
AU2003252478A1 (en) Ccr4 antagonist and medicinal use thereof
AU2003243551A1 (en) Use of an anti-endotoxin drug in the prevention and treatment of disease
AU2002323484A1 (en) Insulin related transcription factor and uses thereof
AU2003255645A1 (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
AU2003235956A1 (en) Quinazoline derivative and medicine
EP1436323A4 (en) Crystal structure of baff, and use thereof in drug design
AU2002341641A1 (en) Crystal structure of interleukin-22 and uses thereof
AU2003269018A1 (en) Acylaminothiazole derivatives, preparation and therapeutic use thereof
AU2002343103A1 (en) Aminoalkylimidazole derivatives and their use in medicine
AU2003281358A1 (en) Pin1 peptidyl-prolyl isomerase polypeptides, their crystal structures, and use thereof for drug design
AU2002308891A1 (en) Novel heterocyclic derivatives and medicinal use thereof
AU2003238242A1 (en) Use of an anti-endotoxin drug in the prevention and treatment of disease
AU2003218261A1 (en) Improvements in pharmaceutical discovery and development
AU2003271016A1 (en) Use of n-acetyl-d-aminoglycosamine in preparation of drugs for the treatment of cacer and metastasis
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
AU2003900495A0 (en) Aroylhydrazone derivatives and therapeutic uses thereof
HK1067372A (en) Crystal structure of baff, and use thereof in drug design
AU2002308105A1 (en) Benzoaxathiepin derivatives and their use as medicines
AU2003264474A1 (en) Novel uracil derivatives and medicinal use thereof
AU2002358661A1 (en) Novel amidine derivatives and the use of the same in pharmaceuticals
AU2002334097A1 (en) Application of the crystal structure of nusa in drug discovery
AU2002365245A1 (en) Crystal structure of yqej and uses thereof